SavedAdd your journal

Journals / Güncel Retina Dergisi / 2017 / Cilt: 1 - Sayı: 4

Idiopathic Choroidal Neovascularizations

İdyopatik Koroidal Neovaskülarizasyonlar

ZAFER CEBECİ
Pages
300–302
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Successful anatomical and functional outcomes can be achieved with application of current treatment modality with anti-vascular endothelial growth factors (VEGF) and with the need of low reinjection numbers

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Idiopathic choroidal neovascularization (ICNV) is a disease that often affects individuals under 50 years of age without an any underlying pathology.
📊
Key Findings & Data:The prognosis of this pathology that often shows unilateral involvement is better than the CNV seen in age-related macular degeneration.
💡
Conclusion & Impact:Successful anatomical and functional outcomes can be achieved with application of current treatment modality with anti-vascular endothelial growth factors (VEGF) and with the need of low reinjection numbers
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Idiopathic choroidal neovascularization (ICNV) is a disease that often affects individuals under 50 years of age without an any underlying pathology. The prognosis of this pathology that often shows unilateral involvement is better than the CNV seen in age-related macular degeneration. Successful anatomical and functional outcomes can be achieved with application of current treatment modality with anti-vascular endothelial growth factors (VEGF) and with the need of low reinjection numbers

Özet

İdyopatik koroidal neovaskülarizasyon (İKNV), altta yatan başka bir patolojinin saptanamadığı, sıklıkla 50 yaşın altındaki bireyleri etkileyen bir hastalıktır. Sıklıkla tek taraflı tutulum gösteren bu patolojinin prognozu yaşa bağlı maküla dejeneresansında görülen KNV'ye göre daha iyidir. Güncel tedavi yöntemi olan anti-vasküler endotelyal büyüme faktörlerinin (VEGF) uygulanması ve düşük sayıdaki tekrar enjeksiyon gereksinimi ile başarılı anatomik ve fonksiyonel sonuçlar elde edilebilmektedir

🔖

Cite This Article

CEBECİ, Z. (2017). Idiopathic Choroidal Neovascularizations. Güncel Retina Dergisi, Cilt: 1 - Sayı: 4, 300–302. https://ajindex.com/articles/224240

References (14)

  1. Grossniklaus HE, Green WR.Choroidal neovascularization.Am j ophthalmol. 2004
  2. 137 (3):496-503 2. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY.Age-related macular degeneration.Lancet. 2012
  3. 379 (9827):1728-1738 3. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ.Etiology of choroidal neovascularization in young patients.Ophthalmology. 1996
  4. 103 (8):1241-1244 4. Ho AC, Yannuzzi LA, Pisicano K, DeRosa J.The natural history of idiopathic subfoveal choroidal neovascularization.Ophthalmology. 1995
  5. 102 (5):782- 789 5. Yang F, Dou HL, Ma Z, Li YL, Lu XR, Wang X, He PP.Serum inflammatory factors in patients with idiopathic choroidal neovascularization.Ocul immunol inflamm. 2010
  6. 18 (5):390-394 6. Yin H, Fang X, Ma J, Chen M, Yang Y, Guo S, Chen Z, Su Z, Feng L, Ye P, Wu F, Yin J.Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment.Scientific reports. 2016
  7. 6 31880 7. Lee JE, Shin MK, Chung IY, Lee JE, Kim HW, Lee SJ, et al.Topographical relationship between the choroidal watershed zone and submacular idiopathic choroidal neovascularisation.Br j ophthalmol. 2016
  8. 100 (5):652-659 8. Chen Q, Yu X, Sun Z, Dai H.The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization.J ophthalmology. 2016
  9. 2016 5608250 9. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group.Arch ophthalmol (Chicago, Ill: 1960) 1993
  10. 111 (9):1200-1209 10. Karacorlu M, Karacorlu S, Ozdemir H.Photodynamic therapy in patients with idiopathic choroidal neovascularization.Jpn j ophthalmol. 2004
  11. 48 (4):422-424 11. Chen YS, Lin JY, Tseng SY, Tang HF, Lee HJ, Lin YR.Photodynamic therapy of idiopathic subfoveal choroidal neovascularization in Taiwanese patients: a 2-year follow-up.Eye (London, England). 2009
  12. 23 (2):314-319 12. Postelmans L, Pasteels B, Coquelet P, El Ouardighi H, Verougstraete C, Schmidt-Erfurth U.Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females.Am j ophthalmol. 2004
  13. 138 (5):803-808 13. Kang HM, Koh HJ.Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization.Am j ophthalmol. 2013
  14. 155 (4):713-719, 719.e711 14. Wang F, Wang W, Yu S, Wang W, Lu F, Xu F, et al. Functional recovery after